curasan Aktie
Personal
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 32 | 35 | 34 | 37 | 38 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,19 | 0,16 | 0,19 | 0,18 | 0,15 |
Bilanz (in Mio. EUR) - Aktiva
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 6 | 6 | 5 | 8 | 5 |
| Summe Anlagevermögen | 8 | 7 | 7 | 7 | 6 |
| Summe Aktiva | 14 | 13 | 13 | 15 | 11 |
Bilanz (in Mio. EUR) - Passiva
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 7 | 4 | 4 | 5 | 4 |
| Summe Eigenkapital | 7 | 9 | 9 | 10 | 8 |
| Summe Passiva | 14 | 13 | 13 | 15 | 11 |
Adresse
| Ernst-Wiss-Strasse 18, 65933 Frankfurt | |
| Telefon | +49 (6027) 40900-0 |
| Internet | http://www.curasan.com |
Management
|
Alexander Baratta
Member-Management Board |
|
Alexander Huwig
Chief Scientific Officer |
|
Andrea Weidner
Head-Corporate Communications |
|
Christine Böhm
Chief Medical Officer |
|
Dirk Dembski
President & Chief Executive Officer |
|
Fabian Franzin
Member-Supervisory Board |
|
Ingo Middelmenne
Head-Investor Relations |
|
Isabella de Krassny
Vice Chairman-Supervisory Board |
|
Karl Arco
Chairman-Supervisory Board |